Live Cancer Drug updates

Live Cancer Drug news coverage of developments with the latest updates. Stay on top of latest Cancer Drug news stories and find out what just happened, what is going on with Cancer Drug. The latest real-time news updates and headlines on Cancer Drug
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
La Trobe Lands $7m For Future-focused Research
Light Transforms Greenhouse Gas Into Pharma Building Block
BC Decriminalization Cuts Drug Arrests, Deaths Unchanged
Man Charged With Bayside Property Crimes
Roadmap For Alcohol And Other Drugs Policy Reform In Australia
Australia Unveils Alcohol, Drug Policy Reform Roadmap
Common Misconceptions About Exercise And Cancer
Police Charge Two Men After Stabbing At Muswellbrook
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Man Charged After $350K Cannabis Bust Near Bathurst
Woman Charged for Smuggling Drugs into Jail
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
Research Finds Low Overdiagnosis In Breast Cancer Screening
Justin Gooding's Journey From Discovery To Impact
UQ Research: Creativity and Impact Highlighted
NT Youth Drug Program Grants 2026/27 Open
St Kilda East Theft and Police Car Ramming Update
Cancer Survival Up, But Legal and Financial Costs Rise
Mullet Man Raises $4K+ for Aussie Prostate Cancer Aid
Centenarian Hosts Prostate Cancer Fundraiser at 100
New Chair Appointed for Australia Day Council
Drug And Weapons Charges, Cannon Hill
KAIST, KIOM Create Wearable Pain-Relief Device
4200km U.S. Trek Promotes Prostate Cancer Awareness
Bungendore Bowls Against Prostate Cancer for Mate
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
End Of Era For Andrew Luciani
Helen Westman Named 2026 Local Hero
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
UNC Unveils Tool to Identify High-Risk Cancer Periods
CU Anschutz Advances Precision Medicine for Rare Cancers
Contraband Seized at Stony Mountain Institution 12 September
Building Better CAR T-Cells For Cancer Treatment